IBDEI09A ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4062,1,1,0)
 ;;=1^Problem Focused
 ;;^UTILITY(U,$J,358.3,4062,1,2,0)
 ;;=2^99241
 ;;^UTILITY(U,$J,358.3,4063,0)
 ;;=99242^^19^230^2
 ;;^UTILITY(U,$J,358.3,4063,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4063,1,1,0)
 ;;=1^Expanded Problem Focus
 ;;^UTILITY(U,$J,358.3,4063,1,2,0)
 ;;=2^99242
 ;;^UTILITY(U,$J,358.3,4064,0)
 ;;=99243^^19^230^3
 ;;^UTILITY(U,$J,358.3,4064,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4064,1,1,0)
 ;;=1^Detailed
 ;;^UTILITY(U,$J,358.3,4064,1,2,0)
 ;;=2^99243
 ;;^UTILITY(U,$J,358.3,4065,0)
 ;;=99244^^19^230^4
 ;;^UTILITY(U,$J,358.3,4065,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4065,1,1,0)
 ;;=1^Comprehensive, Moderate
 ;;^UTILITY(U,$J,358.3,4065,1,2,0)
 ;;=2^99244
 ;;^UTILITY(U,$J,358.3,4066,0)
 ;;=99245^^19^230^5
 ;;^UTILITY(U,$J,358.3,4066,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4066,1,1,0)
 ;;=1^Comprehensive, High
 ;;^UTILITY(U,$J,358.3,4066,1,2,0)
 ;;=2^99245
 ;;^UTILITY(U,$J,358.3,4067,0)
 ;;=99024^^19^231^1
 ;;^UTILITY(U,$J,358.3,4067,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4067,1,1,0)
 ;;=1^Post-Op Follow-up Visit
 ;;^UTILITY(U,$J,358.3,4067,1,2,0)
 ;;=2^99024
 ;;^UTILITY(U,$J,358.3,4068,0)
 ;;=11000^^20^232^1^^^^1
 ;;^UTILITY(U,$J,358.3,4068,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4068,1,2,0)
 ;;=2^11000
 ;;^UTILITY(U,$J,358.3,4068,1,3,0)
 ;;=3^Debride ext eczematous skin,<10%
 ;;^UTILITY(U,$J,358.3,4069,0)
 ;;=11001^^20^232^2^^^^1
 ;;^UTILITY(U,$J,358.3,4069,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4069,1,2,0)
 ;;=2^11001
 ;;^UTILITY(U,$J,358.3,4069,1,3,0)
 ;;=3^Debride ext eczematous skin,Ea 10%
 ;;^UTILITY(U,$J,358.3,4070,0)
 ;;=11042^^20^232^3^^^^1
 ;;^UTILITY(U,$J,358.3,4070,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4070,1,2,0)
 ;;=2^11042
 ;;^UTILITY(U,$J,358.3,4070,1,3,0)
 ;;=3^Debride Subcut (epi/derm);20sq cm or <
 ;;^UTILITY(U,$J,358.3,4071,0)
 ;;=11045^^20^232^4^^^^1
 ;;^UTILITY(U,$J,358.3,4071,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4071,1,2,0)
 ;;=2^11045
 ;;^UTILITY(U,$J,358.3,4071,1,3,0)
 ;;=3^Debride Subcut (epi/derm);Ea Addl 20sq cm
 ;;^UTILITY(U,$J,358.3,4072,0)
 ;;=17000^^20^233^4^^^^1
 ;;^UTILITY(U,$J,358.3,4072,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4072,1,2,0)
 ;;=2^17000
 ;;^UTILITY(U,$J,358.3,4072,1,3,0)
 ;;=3^Destroy 1st Premalignant Lesion
 ;;^UTILITY(U,$J,358.3,4073,0)
 ;;=17004^^20^233^3^^^^1
 ;;^UTILITY(U,$J,358.3,4073,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4073,1,2,0)
 ;;=2^17004
 ;;^UTILITY(U,$J,358.3,4073,1,3,0)
 ;;=3^Destroy 15+ Premalignant Lesions
 ;;^UTILITY(U,$J,358.3,4074,0)
 ;;=17110^^20^233^1^^^^1
 ;;^UTILITY(U,$J,358.3,4074,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4074,1,2,0)
 ;;=2^17110
 ;;^UTILITY(U,$J,358.3,4074,1,3,0)
 ;;=3^Destroy 1-14 Benign Lesions
 ;;^UTILITY(U,$J,358.3,4075,0)
 ;;=17111^^20^233^2^^^^1
 ;;^UTILITY(U,$J,358.3,4075,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4075,1,2,0)
 ;;=2^17111
 ;;^UTILITY(U,$J,358.3,4075,1,3,0)
 ;;=3^Destroy 15+ Benign Lesions
 ;;^UTILITY(U,$J,358.3,4076,0)
 ;;=17003^^20^233^5^^^^1
 ;;^UTILITY(U,$J,358.3,4076,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4076,1,2,0)
 ;;=2^17003
 ;;^UTILITY(U,$J,358.3,4076,1,3,0)
 ;;=3^Destroy 2-14 Premalignant Lesions
 ;;^UTILITY(U,$J,358.3,4077,0)
 ;;=17260^^20^234^1^^^^1
 ;;^UTILITY(U,$J,358.3,4077,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4077,1,2,0)
 ;;=2^17260
 ;;^UTILITY(U,$J,358.3,4077,1,3,0)
 ;;=3^Dest Mal Lesion Tnk/Arm/Leg,0.5cm or <
 ;;^UTILITY(U,$J,358.3,4078,0)
 ;;=17261^^20^234^2^^^^1
 ;;^UTILITY(U,$J,358.3,4078,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4078,1,2,0)
 ;;=2^17261
